LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 70.08 | 27.76 | 10632 | 6849 | 1.5522 | 1.1138 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 70.08 | 27.76 | 9383 | 6849 | 1.3698 | 1.0808 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 70.08 | 27.76 | 9694 | 6849 | 1.4152 | 1.0893 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 71.78 | 27.76 | 747 | 6893 | 0.1084 | 0.5126 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 71.78 | 27.76 | 10944 | 6893 | 1.5877 | 1.1196 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 71.78 | 27.76 | 9715 | 6893 | 1.4094 | 1.0881 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 71.78 | 27.76 | 9940 | 6893 | 1.4420 | 1.0942 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 73.48 | 27.76 | 793 | 6957 | 0.1140 | 0.5229 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 73.48 | 27.76 | 11133 | 6957 | 1.6001 | 1.1215 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 73.48 | 27.76 | 9771 | 6957 | 1.4043 | 1.0871 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 73.48 | 27.76 | 10045 | 6957 | 1.4437 | 1.0943 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 75.19 | 27.76 | 695 | 7015 | 0.0991 | 0.4970 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 75.19 | 27.76 | 11305 | 7015 | 1.6115 | 1.1232 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 75.19 | 27.76 | 9974 | 7015 | 1.4218 | 1.0902 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 75.19 | 27.76 | 10231 | 7015 | 1.4584 | 1.0968 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 76.89 | 27.76 | 674 | 7025 | 0.0959 | 0.4911 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 76.89 | 27.76 | 11559 | 7025 | 1.6454 | 1.1287 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 76.89 | 27.76 | 10071 | 7025 | 1.4336 | 1.0923 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 76.89 | 27.76 | 10358 | 7025 | 1.4744 | 1.0997 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 78.60 | 27.76 | 706 | 7045 | 0.1002 | 0.4995 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 78.60 | 27.76 | 11770 | 7045 | 1.6705 | 1.1327 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 78.60 | 27.76 | 10114 | 7045 | 1.4355 | 1.0926 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 78.60 | 27.76 | 10451 | 7045 | 1.4833 | 1.1012 | MN20160318_Q01 | L07 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 80.31 | 27.76 | 854 | 6976 | 0.1224 | 0.5368 | MN20160318_Q01 | I14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 80.31 | 27.76 | 12036 | 6976 | 1.7253 | 1.1416 | MN20160318_Q01 | I14 |